Pfizer announced that CFO Dave Denton will step down on August 15 to pursue an opportunity in the consumer goods industry, with Cecile Guegan named as Interim CFO effective August 16. The company has initiated a search for a permanent successor while reaffirming its 2026 financial guidance and strategic outlook. Following the announcement, Pfizer's shares experienced a decline, although the company maintained its long-term financial targets.
